BioCentury
ARTICLE | Company News

Lupin, Temmler deal

September 7, 2015 7:00 AM UTC

Lupin will acquire a portfolio of 13 products from Temmler. The portfolio includes products to treat myasthenia gravis, Huntington disease (HD) and warts. The companies did not respond to inquiries. ...